1Slemp AE,Kirschner RE. Keloids and scars:a review of keloids and scars,their pathogenesis,risk factors,and management[J].{H}Current Opinion in Pediatrics,2006,(04):396-402.
3Dustan HP. Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? Hypertension, 1995,26(6 Pt 1 ):858-862.
5Ghazizadeh M, Miyata N, Sasaki Y, et al. Silver-stained nucleolar organizer regions in hypertrophic and keloid scars. Am J Dermatopathol,1997, 19(5) :468-472.
6Alaish SM, Yager DR, Diegelmann RF, et al. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg, 1995, 30(7) :949-952.
7Marneros AG, Norris JE, Olsen BR, et al. Clinical genetics of familial keloids. Arch Dermatol, 2001, 137 ( 11 ): 1429-1434.
8Saed GM, Ladin D, Olson J, et al. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dennatol, 1998, 134(8) :963-967.
9Nirodi CS, Devalaraja R, Nanney LB, et al. Chemokine and chemokine receptor expression in keloid and normal fibroblasts. Wound Repair Regen, 2000, 8(5) :371-382.
10Peltonen J, Hsiao LL, Jaakkola S, et al. Activation of collagen gene expression in keloids: co-localization of type Ⅰ and Ⅵ collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol, 1991,97(2) :240-248.
